Eisai Co., Ltd. approved the appointment of Eiichiro Suhara as independent Director at ordinary general meeting of shareholders held on June 19, 2015.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6,560 JPY | -1.00% |
|
-1.01% | -6.98% |
07-02 | Eli Lilly Alzheimer's drug approved by US FDA | RE |
07-02 | Eisai Repurchases 4.8 Billion Yen Worth of Shares in June | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.98% | 11.73B | |
+55.55% | 816B | |
+39.65% | 634B | |
-6.83% | 351B | |
+17.15% | 323B | |
+7.09% | 293B | |
+13.68% | 238B | |
+1.19% | 222B | |
+13.16% | 218B | |
+7.87% | 167B |
- Stock Market
- Equities
- 4523 Stock
- News Eisai Co., Ltd.
- Eisai Co., Ltd. Appoints Eiichiro Suhara as Independent Director